H.R. 6610 · 119th Congress

Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]

Introduced on Dec 11, 2025 by Jake Auchincloss (D-MA-4). 46 cosponsors, 27 of them from another party. Latest action (Jul 22, 2026): Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.

Stage
Introduced
Introduced
Dec 11, 2025
Cosponsors
46
27 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes.

Subjects

  • Civil actions and liability
  • Government employee pay, benefits, personnel management
  • Health care costs and insurance
  • Judicial review and appeals
  • Prescription drugs
  • User charges and fees

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Jake AuchinclossD-MA-4Sponsor

Democrats · 19

Republicans · 27

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Dec 11, 2025Introduced in House
  2. Dec 11, 2025Introduced in House
  3. Dec 11, 2025 · HouseReferred to the House Committee on Oversight and Government Reform.
  4. Jul 22, 2026 · HouseCommittee Consideration and Mark-up Session Held
  5. Jul 22, 2026 · HouseOrdered to be Reported (Amended) by the Yeas and Nays: 40 - 2.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. INDEPENDENT PHARMACY COOPERATIVE4 reports
    $170K reported (all issues)Federal contractor: INDEPENDENT PHARMACY COOPERATIVEAI match · 99%
  2. CVS HEALTH3 reports
    $9.2M reported (all issues)
  3. NATIONAL COMMUNITY PHARMACISTS ASSOCIATION3 reports
    $820K reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  4. NATIONAL TREASURY EMPLOYEES UNION3 reports
    $1M reported (all issues)
  5. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION3 reports
    $9.5M reported (all issues)
  6. URAC3 reports
  7. Blue Cross and Blue Shield Association1 report
    $1.4M reported (all issues)
  8. Blue Cross and Blue Shield of Florida, Inc.1 report
    $90K reported (all issues)
  9. GSK (fka GLAXOSMITHKLINE INC.)1 report
    $890K reported (all issues)
  10. GUIDEWELL MUTUAL HOLDING CORPORATION1 report
  11. National Association of Letter Carriers1 report
    $140K reported (all issues)
  12. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA1 report
    $7.4M reported (all issues)
  13. Transparency Rising Corp.1 report
  14. Transparency-Rx Corp.1 report
    $20K reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.